Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Archives of Internal Medicine

• Publication date

  2008-03-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/archinternmed.2007.82PMID 18332299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnosis of Advanced Cancer Among Elderly Medicare and Medicaid Patients

  2007cited by this paper
• The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer

  2007cited by this paper
• Medicaid, Medicare, and the Michigan Tumor Registry: A Linkage Strategy

  2007cited by this paper
• Survival rates for stage II colon cancer patients treated with or without chemotherapy in a population-based setting

  2007cited by this paper
• Completion of therapy by Medicare patients with stage III colon cancer.

  2006cited by this paper
• Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer

  2006cited by this paper
• New approaches to the adjuvant therapy of colon cancer.

  2006cited by this paper
• Adjuvant chemotherapy for colon cancer.

  2006cited by this paper
• Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer.

  2006cited by this paper
• In Search of the Perfect Comorbidity Measure for Use With Administrative Claims Data: Does It Exist?

  2006cited by this paper
• Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation.

  2005cited by this paper
• Explaining black-white differences in receipt of recommended colon cancer treatment.

  2005cited by this paper
• Cancer, Medicaid enrollment, and survival disparities

  2005cited by this paper
• Unequal Treatment—Confronting Racial and Ethnic Disparities in Healthcare

  2004cited by this paper
• Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

  2004cited by this paper
• Older Patients with Colon Cancer: Is Adjuvant Chemotherapy Safe and Effective?

  2003cited by this paper
• Comparison of the American Society of Anesthesiologists Physical Status classification with the Charlson score as predictors of survival after radical prostatectomy.

  2003cited by this paper
• Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort.

  2003cited by this paper
• Unequal treatment: confronting racial and ethnic disparities in health care.

  2003cited by this paper
• Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study.

  2002cited by this paper
• Medicaid enrollment among elderly medicare beneficiaries: individual determinants, effects of state policy, and impact on service use.

  2002cited by this paper
• A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.

  2001cited by this paper
• Adjuvant chemotherapy for colon cancer

  2001cited by this paper
• Age and adjuvant chemotherapy use after surgery for stage III colon cancer.

  2001cited by this paper
• Development of a comorbidity index using physician claims data.

  2000cited by this paper
• Measuring comorbidity in older cancer patients.

  2000cited by this paper
• Rural physicians' understanding of the state-of-the-art in breast, colon and rectum cancer treatment

  1999cited by this paper
• Treatment differences between blacks and whites with colorectal cancer.

  1996cited by this paper
• Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

  1992cited by this paper
• Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

  1990cited by this paper
• Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

  1989cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper
• International classification of diseases: ninth revision.

  1978cited by this paper

• Impact of Medicaid Expansion on Treatment and Outcomes in Patients Undergoing Surgery for Common Colorectal Conditions.

  2025cites this paper
• Pancreatic Cancer with Vascular Involvement: Adherence to Current Standard-of-Care Associated with Improved Survival

  2023cites this paper
• Adjuvant Chemotherapy Is Associated with Improved Survival for Stage III Colon Cancer When Initiated Beyond 8 Weeks

  2023cites this paper
• Predicting loss of independence after high-risk gastrointestinal abdominal surgery: Frailty vs. NSQIP risk calculator.

  2022cites this paper
• Clinical and Therapeutic Characteristics of Cancer Patients in the Southern Region of Saudi Arabia: A Cross-Sectional Study

  2021cites this paper
• Impact of Insurance Status on Oncologic and Perioperative Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

  2021cites this paper
• Die neoadjuvante und adjuvante Therapie des resektablen Kolonkarzinoms: Aktuelle Standards und Entwicklungen

  2021cites this paper
• Personalized Adjuvant Treatment of Colon Cancer

  2020cites this paper
• Non-Adherence to Standard of Care for Locally Advanced Colon Cancer as a Contributory Factor for High Mortality Rates in Kentucky.

  2020cites this paper
• Principles of Cancer Targeted Therapy in Older Adults

  2020cites this paper
• Development of a Model for Predicting Early Discontinuation of Adjuvant Chemotherapy in Stage III Colon Cancer.

  2020cites this paper
• N1c colon cancer and the use of adjuvant chemotherapy: a current audit of the National Cancer Database

  2020cites this paper
• New prognostic risk score for predicting in-hospital mortality in geriatric patients undergoing colorectal cancer surgery: U.S. Nationwide Inpatient Sample analysis.

  2020cites this paper
• Patient- and tumor-related predictors of chemotherapy intolerance in older patients with cancer: A systematic review.

  2019cites this paper
• Role of pre-existing type 2 diabetes in colorectal cancer survival among older Americans: a SEER-Medicare population-based study 2002–2011

  2019cites this paper
• Treatment selection bias for chemotherapy persists in colorectal cancer patient cohort studies even in comprehensive propensity score analyses

  2019cites this paper
• Treatment selection bias for chemotherapy persists in colorectal cancer patient cohort studies even in comprehensive propensity score analyses

  2019cites this paper
• Treatment selection bias for chemotherapy persists in colorectal cancer patient cohort studies even in comprehensive propensity score analyses

  2019cites this paper
• CLEP_A_215983 821..832

  2019cites this paper
• The impact of comorbidity on mortality in Danish sarcoma patients from 2000-2013: A nationwide population-based multicentre study

  2018cites this paper
• Competing nomograms help in the selection of elderly patients with colon cancer for adjuvant chemotherapy

  2018cites this paper
• Effects of being uninsured or underinsured and living in high poverty neighborhoods on colon cancer care and survival in California: historical cohort analysis, 1996—2011

  2018influential citation
• Age-adjusted charlson comorbidity index score as predictor of prolonged postoperative ileus in patients with colorectal cancer who underwent surgical resection

  2017cites this paper
• Personalizing Adjuvant Therapy for Stage II/III Colorectal Cancer.

  2017cites this paper
• Trends in Cancer Survival by Health Insurance Status in California From 1997 to 2014

  2017cites this paper
• Sociodemographic factors associated with stage of diagnosis and treatment uptake among patients with colorectal cancer: A brief report

  2017cites this paper
• Age-adjusted Charlson comorbidity index score as predictor of survival of patients with digestive system cancer who have undergone surgical resection

  2017cites this paper
• Is distance to chemotherapy an obstacle to adjuvant care among the N.C. Medicaid-enrolled colon cancer patients?

  2016cites this paper
• Increasing Consumer Engagement by Tailoring a Public Reporting Website on the Quality of Diabetes Care: A Qualitative Study

  2016cites this paper
• Comorbidity in older adults with cancer.

  2016cites this paper
• Impact of age on efficacy of postoperative oxaliplatin-based chemotherapy in patients with rectal cancer after neoadjuvant chemoradiotherapy

  2016cites this paper
• Patterns of Care for Metastatic Colorectal Cancer in Appalachia, and the Clinical, Sociodemographic, and Service Provider Determinants.

  2016cites this paper
• Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort.

  2016cites this paper
• Age-Adjusted Charlson Comorbidity Index Scores as Predictor of Survival in Colorectal Cancer Patients Who Underwent Surgical Resection and Chemoradiation

  2015cites this paper
• Does Patient Rurality Predict Quality Colon Cancer Care?: A Population-Based Study

  2015cites this paper
• Pathways to colonoscopy in the South: seeds of health disparities.

  2015cites this paper
• Radiotherapy associated with improved survival for high‐grade sarcoma of the extremity

  2015cites this paper
• Can we achieve an 80% screening rate for colorectal cancer by 2018 in the United States?

  2015cites this paper
• The Impact of Delayed Chemotherapy on Its Completion and Survival Outcomes in Stage II Colon Cancer Patients

  2014cites this paper
• The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago.

  2014cites this paper
• Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy?

  2014cites this paper
• Adjuvant Chemotherapy for Stage II Right-Sided and Left-Sided Colon Cancer: Analysis of SEER-Medicare Data

  2014cites this paper
• Comparison of Compliance of Adjuvant Chemotherapy Between Laparoscopic and Open Surgery in Patients With Colon Cancer

  2014cites this paper
• The effect of health insurance status on the treatment and outcomes of patients with colorectal cancer

  2014cites this paper
• Assessment of comorbidities in surgical oncology outcomes

  2014cites this paper
• Insurance Payer Status and Race Explains Much of the Variability in Colorectal Cancer Survival

  2014cites this paper
• Patterns of colorectal cancer care in the United States and Canada: a systematic review.

  2013cites this paper
• Age-Related Treatment Disparities among Medicaid Beneficiaries with Metastatic Colorectal Cancer

  2013cites this paper
• Predictors of Short-Term Postoperative Survival After Elective Colectomy in Colon Cancer Patients ≥80 Years of Age

  2013cites this paper
• Comparative Effectiveness of Adjuvant Chemotherapy in Elderly Colon Cancer Patients

  2013cites this paper
• The impact of comorbidity on cancer survival: a review

  2013cites this paper
• Patterns of Pelvic Radiotherapy in Patients with Stage II/III Rectal Cancer

  2013cites this paper
• Better colon cancer care for extremely poor Canadian women compared with American women.

  2013cites this paper
• A checklist for ascertaining study cohorts in oncology health services research using secondary data: report of the ISPOR oncology good outcomes research practices working group.

  2013cites this paper
• Cancer Treatment for Dual Eligibles: What Are the Costs and Who Pays?

  2013cites this paper
• Effects of being uninsured or underinsured and living in extremely poor neighborhoods on colon cancer care and survival in California: historical cohort analysis, 1996—2011

  2012influential citation
• Measuring colorectal cancer care quality for the publicly insured in New York State

  2012cites this paper
• Cancer outcomes in low-income elders: is there an advantage to being on Medicaid?

  2012cites this paper
• Hospital factors and patient characteristics in the treatment of colorectal cancer: a population based study

  2012cites this paper
• Comparative Effectiveness of Different Chemotherapeutic Regimens on Survival of People Aged 66 and Older with Stage III Colon Cancer: A “Real World” Analysis Using Surveillance, Epidemiology, and End Results–Medicare Data

  2011cites this paper
• Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.

  2011cites this paper
• Effects of socioeconomic status on colon cancer treatment accessibility and survival in Toronto, Ontario, and San Francisco, California, 1996-2006.

  2011cites this paper
• Incremental Value of Using Medicaid Claim Files to Study Comorbid Conditions and Treatments in Dually Eligible Beneficiaries

  2010cites this paper
• Age and rural residence effects on accessing colorectal cancer treatments: a registry study.

  2010cites this paper
• The Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colorectal Cancer is Independent of Age and Comorbidity.

  2010cites this paper
• Comorbidities, functional limitations, and geriatric syndromes in relation to treatment and survival patterns among elders with colorectal cancer.

  2010cites this paper
• The utility of the state buy-in variable in the Medicare denominator file to identify dually eligible Medicare-Medicaid beneficiaries: a validation study.

  2010cites this paper
• Adjuvant Chemotherapy Among Medicaid-Enrolled Patients Diagnosed With Nonmetastatic Colon Cancer

  2010cites this paper
• Nursing Home Organizational Characteristics and Utilization of Cancer-Related Medical Services

  2010influential citation
• Health Care System Approaches for Cancer Patient Communication

  2009cites this paper
• Effect of Age on Survival Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer

  2009cites this paper
• Chemotherapy for the Older Adult with Cancer

  2009cites this paper
• Gastrointestinal malignancies: when does race matter?

  2009cites this paper
• Inadequate Access to Surgeons: Reason for Disparate Cancer Care?

  2009cites this paper
• Trends in Disparities in Receipt of Adjuvant Therapy for Elderly Stage III Colon Cancer Patients: The Role of the Medical Oncologist Evaluation

  2009cites this paper
• Scholarship at UWindsor Scholarship at UWindsor

  year unknowncites this paper